NPPA~India🇮🇳

Official handle of 'National #Pharmaceuticals Pricing Authority of India (#NPPA)'. RTs= RTs; Mission: ''#AffordableMedicinesForAll''.

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Biopharmaceuticals are shaping the future of modern healthcare and India is well-positioned to emerge as a global leader in this transformative sector. The Government of India is committed to strengthening innovation, manufacturing, clinical research, and regulatory capabilities to make India a leading global biopharmaceutical hub, said Smt. Anupriya Patel, Union Minister of State for Chemicals & Fertilizers.

Read More : https://t.co/jmrGacR5kY

[ANI_HindiNews @AHindinews]

नेशनल फार्मास्युटिकल प्राइसिंग अथॉरिटी ने 30 दवाइयों के फॉर्मूलेशन की रिटेल कीमत तय कर दी है, जिसमें विटामिन D3 ओरल सॉल्यूशन, कैल्शियम, विटामिन D3, मिथाइलकोबालामिन, L-मिथाइलफोलेट कैल्शियम, पाइरिडोक्सल-5 फॉस्फेट और दूसरी दवाएं शामिल हैं।

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

New comprehensive support scheme for discovery and development in Bulk Drugs says Shri Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers in an interview with Business Standard

[NPPA~India🇮🇳 @nppa_india]

Explore the twenty-eighth issue of NPPA's bi-monthly e-newsletter- #AUSHADH_SANDESH, on drug price regulation, policy updates, and initiatives. Read English version on: https://t.co/yTjTtRey2r #PharmaSahiDaam

[NPPA~India🇮🇳 @nppa_india]

#Goa #PMRU #Pharma_Sahi_Daam #NPPA

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Pharma this Month (May)
#Pharmaceuticals #Pharma_this_month

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

On the occasion of National Technology Day 2026, National Institute of Pharmaceutical Education and Research Mohali, National Institute of Pharmaceutical Education and Research Raebareli, and National Institute of Pharmaceutical Education and Research Hyderabad and National Institute of Pharmaceutical Education and Research, Kolkata showcased cutting-edge indigenous technologies in biotechnology, advanced drug delivery, green chemistry, neuroprotective therapeutics, nanotechnology, and rapid diagnostics at the exhibition organised by
@DBTIndia in New Delhi as part of the Vigyan TECH 2026 celebrations. The exhibition was inaugurated by Hon’ble Minister of State Dr. Jitendra Singh.

The innovations included a novel bispecific antibody platform, Direct Powder Extrusion (DPE) technology, green synthesis approaches for neuroprotective compounds, sustainable catalytic processes with industrial scale-up potential, advanced dendrimer and plant exosome-based drug delivery systems, rapid sepsis diagnostics for critical care applications, and industry-transferred fluorescent probe technologies for biomedical imaging and disease diagnostics. These technologies highlight India’s growing strength in translational research and their potential impact across healthcare, pharmaceuticals, biotechnology, and diagnostics, reinforcing the vision of #AtmanirbharBharat through affordable and scalable innovation.

➡️NIPER, Mohali showcased advanced technologies including “BiSpekDAb”, a novel bispecific antibody platform, and “SingleStep Direct Powder Extrusion (DPE)” technology for pharmaceutical applications.

➡️ NIPER, Raebareli presented innovative technologies in neuroprotective therapeutics and green chemistry. The showcased innovations included a catalyst-free green synthesis approach for Kynurenic Acid derivatives with neuroprotective potential, sustainable annulation technologies for industrial translation, advanced dendrimer-based targeted drug delivery systems, and plant exosome-based nanotechnology for diagnostics and therapeutics.

#विज्ञानTech2026 #NationalTechnologyDay #राष्ट्रीयप्रौद्योगिकीदिवस #ViksitBharat

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Pharma this Month (APRIL)

#Pharmaceuticals #Pharma_this_month

[NPPA~India🇮🇳 @nppa_india]

#PMRU #Tripura #Pharma_Sahi_Daam

[AiMeD @MiIAiMeD]

@JPNadda @OfficeofJPNadda
Glad that @Pharmadept @nppa_india @MoHFW_INDIA is in discussion to review the price regulations on medical devices as ethical manufacturers are loosing out and frustrated in ability to satisfy their desire to provide relief to patients n consumers of access to affordable medical devices. All stakeholders- @ahpi_india @bejonmisra @IMAIndiaOrg @SMTA_India - representing healthcare providers , doctors consumers , distributors so what’s ethical and rational markup at each stage of supply chain once goods enter the Indian market and GST applied initially- in case of imports on overseas manufacturers Import landed price & Indian manufacturers discounted ex factory prices- is permitted to arrive at a Fair Price to consumers, this will also help Insurance Companies to reduce their premium and the insurance coverage net can be widened to cover all consumers as envisioned in Health for All . The timing is opportune to launch pilots on various suggestions to provide Policy Making on Evidence basis on Fair Prices instead of ongoing Misleading Inflated MRP

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

India’s biopharmaceutical landscape is at a decisive turning point. While regulatory reforms have laid a strong foundation, the next phase demands deeper alignment between industry and health authorities-especially on timelines, expectations, and execution. Encouragingly, timelines are already shrinking, signaling a more responsive ecosystem. Yet, the real opportunity lies in building confidence for companies to invest, innovate, and manufacture within India rather than looking abroad. With sustained dialogue, policy stability, and a focus on retaining momentum, the sector is poised for a powerful transformation over the next few years. Strengthening domestic capabilities will not only reduce dependence on external systems but also position India as a reliable partner for global biopharmaceutical development. The shift is clear, from participation to leadership, from reliance to resilience, and from potential to performance : Shri Manoj Joshi, Secretary, Department of Pharmaceuticals

#IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

India is steadily transforming from the 'Pharmacy of the world' to a global bio-pharma hub, calling for bold thinking and decisive next steps. The focus is clear, expanding access to affordable biosimilars that meet global healthcare needs while strengthening health security through a more resilient ecosystem. As the industry undergoes this transition, readiness and innovation will be key. The government is placing strong emphasis on advancing the bio-pharma sector, an area where India has vast untapped potential, with active support for industry growth. Investments in human resources and the integration of AI in drug discovery and development are set to accelerate progress. Strengthening institutions like NIPERs, with plans for 3 new centres, will further enhance industry-academia collaboration. With a renewed push for research and development, the vision is clear-to build a world-class bio-pharma powerhouse through collective efforts of government, industry, and stakeholders : Smt Anupriya Patel, Minister of state for Chemicals and Fertilizers

#IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

India continues to strengthen its position as the Pharmacy of the world, driven by affordable generic medicines and a growing focus on innovation. With increasing emphasis on biosimilars and specialty medicine, the sector is evolving rapidly. Through initiatives supporting research, domestic manufacturing, and resilient supply chains, India is enhancing self-reliance while expanding its global footprint. India Pharma reflects the strength and rising global relevance of India’s pharmaceutical sector, as stakeholders come together to build a more resilient, inclusive, and innovation-driven healthcare ecosystem. : Shri Jagat Prakash Nadda, Minister of Chemicals & Fertilizers

#IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

“In the context of strengthening India’s pharmaceutical ecosystem, our focus as the Health Ministry is on ensuring early availability, easier accessibility and quality of medicines, so that public health services can be delivered more effectively to every citizen.” : Smt. Punya Salila Srivastava
Secretary, Ministry of Health and Family Welfare, Government of India

#IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

Only 1 day to go until India Pharma 2026 convenes the brightest minds from policy, science, and industry under one roof.

The countdown is almost over as leaders and innovators prepare to engage in conversations that will define the next era of pharmaceuticals and life sciences in India and beyond.

The 9th edition of India Pharma 2026 is being organised by the Department of Pharmaceuticals, Government of India, in association with FICCI and the Indian Pharmaceutical Alliance (IPA).

Date : 13th & 14th April 2026
Venue : FICCI Federation House, New Delhi

#IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

We have three PLI schemes in pharmaceutical sector—one for formulation industry, the largest scheme, which has done quite well with investments more than about Rs 40,000 crore and production much more than four times the target; the second for bulk drugs or API with about Rs 4000 crore investment. We will support fermentation-based industry through bio-pharma mission also; the third PLI for medical devices has seen strong success in higher-end machines, imaging and implants with rising investments and sales, though consumables need better production and quality, while overall ecosystem in India is developing :Shri Manoj Joshi, Secretary, Department of Pharmaceuticals

Link: https://t.co/soJPMHmXqs

Watch the full Interview with ETNow

#Bulkdrugs #API #PLI #pharmaceuticals

[India Pharma 2026 @IndiaPharma2026]

Shri Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, will be speaking at Plenary Session 1: “Policy Thrust for Catalysing Innovation” at India Pharma 2026.

This session will focus on building a forward-looking policy ecosystem to drive innovation, encourage investment, and position India as a global life sciences leader.

Join the leaders shaping the future of pharma at the 9th edition of India Pharma 2026, organised by the Department of Pharmaceuticals, Government of India, in association with FICCI and the Indian Pharmaceutical Alliance (IPA).

📅 13th & 14th April 2026
📍 FICCI Federation House, New Delhi

#IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

2 days to go until India Pharma 2026 brings together the brightest minds in policy, science, and industry under one roof. Be part of the conversations shaping the next era of pharmaceuticals and life sciences in India and beyond. The 9th edition of India Pharma 2026 is being organised by the Department of Pharmaceuticals, Government of India, in association with FICCI and the Indian Pharmaceutical Alliance (IPA).

Date : 13th & 14th April 2026
Venue : FICCI Federation House, New Delhi

#IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

The Government remains fully engaged in facilitating supplies on a case-by-case basis, with active support from the Ministry of Petroleum and Natural Gas, to ensure uninterrupted production of essential medicines : Shri Satyaprakash T L, Joint Secretary, Department of Pharmaceuticals

@PIB_India @PIBHindi @DDNewslive @mygovindia @airnewsalerts

#EnergySecurity

[Department of Pharmaceuticals 🇮🇳 @Pharmadept]

I am happy to share that the Department of Pharmaceuticals, along with FICCI and the Indian Pharmaceutical Alliance, is organising the 9th edition of India Pharma 2026 With the theme ‘Discovering India, Leapfrogging Life Science Innovation’, the event highlights India’s journey from the pharmacy of the world to a global leader in pharma innovation and research. Join us in shaping the future of healthcare - From India, For the World : Shri Awadhesh Kumar Choudhary, Economic Advisor, Department of Pharmaceuticals

@IndiaPharma2026 @PIB_India @mygovindia

#IndiaPharma2026 #PharmaInnovation #LifeSciences #HealthcareIndia